Safe Orthopaedics Posts 37% Second Quarter Sales Increase
Tracey Romero • Mon, July 17th, 2017
Safe Orthopaedics announced on Monday, July 10, 2017, that sales for the second quarter 2017 rose 37% (excluding currency and acquisitions). Sales for the quarter were €880 thousand, which is up from €643 thousand reported in the second quarter of 2016.
Safe Orthopaedics, which is based in Eragny-sur-Oise, France, specializes in sterile implants and single-use instruments for spinal surgery. The following table shows the sales details for second quarter 2017.
According to a press release, France continued an upward trend from the first quarter with a growth of 29% in the second quarter. In the rest of the world, the 44% increase in second quarter 2017 revenue was due in part to the continued growth of sales in Mexico and Germany.
“Our second-quarter 2017 revenues demonstrate the benefits of our strategic realignment. For the third quarter in a row, we have achieved a high level of growth”, said Pierre Dumouchel, chief executive officer of Safe Orthopaedics in a press release.
He added, “To maintain this brisk pace of growth in Europe and in emerging markets, we will continue to promote the benefits of our technologies for minimally-invasive and trauma surgeries. What’s more the recent additions to our sales and marketing teams in France and Germany should unlock major growth opportunities over the next few quarters.